397 related articles for article (PubMed ID: 33786894)
21. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
22. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
23. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
Jiang T; Tan L; Zhu XC; Zhou JS; Cao L; Tan MS; Wang HF; Chen Q; Zhang YD; Yu JT
Neurobiol Aging; 2015 Dec; 36(12):3176-3186. PubMed ID: 26364736
[TBL] [Abstract][Full Text] [Related]
24. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore.
Gussago C; Casati M; Ferri E; Arosio B
J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).
Atagi Y; Liu CC; Painter MM; Chen XF; Verbeeck C; Zheng H; Li X; Rademakers R; Kang SS; Xu H; Younkin S; Das P; Fryer JD; Bu G
J Biol Chem; 2015 Oct; 290(43):26043-50. PubMed ID: 26374899
[TBL] [Abstract][Full Text] [Related]
26. TREM2 and the Progression of Alzheimer's Disease.
Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
[TBL] [Abstract][Full Text] [Related]
27. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
[TBL] [Abstract][Full Text] [Related]
28. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
29. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
[TBL] [Abstract][Full Text] [Related]
30. The role of triggering receptor expressed on myeloid cells 2 in Parkinson's disease and other neurodegenerative disorders.
Schwarz H; Bässler S; Balta D; Socher E; Zunke F; Arnold P
Behav Brain Res; 2022 Sep; 433():113977. PubMed ID: 35752274
[TBL] [Abstract][Full Text] [Related]
31. A novel homozygous mutation in TREM2 found in a Chinese early-onset dementia family with mild bone involvement.
Li X; Sun Y; Gong L; Zheng L; Chen K; Zhou Y; Gu Y; Xu Y; Guo Q; Hong Z; Ding D; Fu J; Zhao Q
Neurobiol Aging; 2020 Feb; 86():201.e1-201.e7. PubMed ID: 30797549
[TBL] [Abstract][Full Text] [Related]
32. Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.
Guerreiro R; Bilgic B; Guven G; Brás J; Rohrer J; Lohmann E; Hanagasi H; Gurvit H; Emre M
Neurobiol Aging; 2013 Dec; 34(12):2890.e1-5. PubMed ID: 23870839
[TBL] [Abstract][Full Text] [Related]
33. TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients.
Peplonska B; Berdynski M; Mandecka M; Barczak A; Kuzma-Kozakiewicz M; Barcikowska M; Zekanowski C
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):407-412. PubMed ID: 29557178
[TBL] [Abstract][Full Text] [Related]
34. TREM2 Function in Alzheimer's Disease and Neurodegeneration.
Ulrich JD; Holtzman DM
ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967
[TBL] [Abstract][Full Text] [Related]
35. Different Splice Isoforms of Peripheral Triggering Receptor Expressed on Myeloid Cells 2 mRNA Expressions are Associated With Cognitive Decline in Mild Dementia Due to Alzheimer's Disease and Reflect Central Neuroinflammation.
Chiang YK; Lin YS; Chen CY; Lirng JF; Yang YH; Lee WJ; Fuh JL
Am J Alzheimers Dis Other Demen; 2024; 39():15333175241243183. PubMed ID: 38592304
[TBL] [Abstract][Full Text] [Related]
36. Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases.
Han J; Wang M; Ren M; Lou H
Int J Neurosci; 2017 Apr; 127(4):368-375. PubMed ID: 27871212
[TBL] [Abstract][Full Text] [Related]
37. Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function.
Dash R; Munni YA; Mitra S; Choi HJ; Jahan SI; Chowdhury A; Jang TJ; Moon IS
Sci Rep; 2022 Jun; 12(1):9378. PubMed ID: 35672339
[TBL] [Abstract][Full Text] [Related]
38. TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia.
Lattante S; Le Ber I; Camuzat A; Dayan S; Godard C; Van Bortel I; De Septenville A; Ciura S; Brice A; Kabashi E;
Neurobiol Aging; 2013 Oct; 34(10):2443.e1-2. PubMed ID: 23759145
[TBL] [Abstract][Full Text] [Related]
39. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
Neumann H; Takahashi K
J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
[TBL] [Abstract][Full Text] [Related]
40. TREM2 in CNS homeostasis and neurodegenerative disease.
Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
